
Joy Ventures
AI Verified
Israel
Venture Capital
11 Ha-Menofim Street, Herzliya, Tel Aviv District, Israel
2017
Criteria | Requirements | Match |
---|---|---|
Regions | Middle East, North America, Northern Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Series A, Seed, Growth Stage, Pre-Seed |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
Corundum Neuroscience operates as both a venture builder and investment fund dedicated to transforming groundbreaking neuroscience research into practical applications. By bridging the gap between laboratory discoveries and real-world implementation, the firm plays a crucial role in advancing neurological health solutions. Their comprehensive approach encompasses the entire innovation journey, from initial concept development through commercialization, ensuring promising neuroscience technologies reach their full market potential.
The investment team brings together deep domain expertise in neuroscience with proven venture-building capabilities, creating a powerful combination that addresses the unique challenges of CNS-focused startups. This specialized knowledge allows Corundum to effectively evaluate complex neurological technologies, identify promising therapeutic approaches, and guide scientific founders through the intricate regulatory landscape that often accompanies neuroscience innovations. Their hands-on methodology provides portfolio companies with strategic guidance beyond typical financial investment.
Adopting a patient capital approach, Corundum Neuroscience makes strategic investments with extended time horizons, acknowledging the typically longer development cycles required for neuroscience breakthroughs. The firm focuses on specific disease areas and targeted outcomes, prioritizing solutions with clear therapeutic potential. Their portfolio spans various neuroscience applications including neurodegeneration, psychiatric disorders, neuromodulation technologies, and cognitive enhancement platforms, reflecting their commitment to addressing diverse neurological challenges.
Beyond financial returns, Corundum measures success through the tangible impact their investments make on human health and wellbeing. The firm actively collaborates with academic institutions, research laboratories, and established healthcare organizations to create an ecosystem that nurtures neuroscience innovation. By supporting researchers and entrepreneurs throughout the development process, Corundum Neuroscience ultimately aims to deliver solutions that meaningfully improve neurological health outcomes, enhance longevity, and contribute to overall quality of life for patients worldwide.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
Joy Ventures maintains its global headquarters in Israel, serving as the strategic center for its operations. The company's primary corporate offices are located at 11 Ha-Menofim Street, Herzliya, Tel Aviv District, Israel.
Joy Ventures focuses its investment activities on companies operating in the following stages: Series A, Seed, Growth Stage, Pre-Seed. Joy Ventures provides strategic capital and expertise to support promising businesses at these critical phases of development.
Joy Ventures maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Middle East, North America, Northern Europe.
Joy Ventures was established in 2017, marking the beginning of its journey as an investment firm.
Joy Ventures is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.